Skip to main content
SpringerLink
Log in

A Case of a Large, Invasive PTC with Gross Residual Disease (pT4) After Surgery

  • Chapter
Thyroid Cancer

  • 1920 Accesses

Abstract

Residual, unresectable disease following thyroidectomy for differentiated thyroid cancer is an uncommon but challenging situation. This chapter reviews the role of external beam radiotherapy in addition to radioactive iodine and, in these cases, specifically the evidence for external beam radiotherapy and the controversy around radiotherapy volume and dose.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Brierley J, Tsang R, Panzarella T, Bana N. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Clin Endocrinol (Oxf). 2005;63:418–27.

    Article  CAS  Google Scholar 

  2. Biermann M, Pixberg M, Riemann B, Schuck A, Heinecke A, Schmid KW, Willich N, Dralle H, Schober O, MSDS Study Group. Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer - results after 874 patient-years of follow-up in the MSDS-trial. Nuklearmedizin. 2009;48:89–98; quiz N15.

    PubMed  Google Scholar 

  3. American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214.

    Article  Google Scholar 

  4. Brierley JD. Update on external beam radiation therapy in thyroid cancer. J Clin Endocrinol Metab. 2011;96:2289–95.

    Article  CAS  PubMed  Google Scholar 

  5. Terezakis SA, Lee KS, Ghossein RA, Rivera M, Tuttle RM, Wolden SL, Zelefsky MJ, Wong RJ, Patel SG, Pfister DG, Shaha AR, Lee NY. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: memorial sloan-kettering cancer center experience. Int J Radiat Oncol Biol Phys. 2009;73:795–801.

    Article  PubMed  Google Scholar 

  6. Azrif M, Slevin NJ, Sykes AJ, Swindell R, Yap BK. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation. Radiother Oncol. 2008;89:105–13.

    Article  PubMed  Google Scholar 

  7. Sia MA, Tsang RW, Panzarella T, Brierley JD. Differentiated thyroid cancer with extrathyroidal extension: prognosis and the role of external beam radiotherapy. J Thyroid Res. 2010;2010:183461.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999;45:577–87.

    Article  CAS  PubMed  Google Scholar 

  9. Feng FY, Kim HM, Lyden TH, Haxer MJ, Feng M, Worden FP, Chepeha DB, Eisbruch A. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2007;68:1289–98.

    Article  PubMed  Google Scholar 

  10. O'Sullivan B, Rumble RB, Warde P, Members of the IIEP. Intensity-modulated radiotherapy in the treatment of head and neck cancer. Clin Oncol. 2012;24:474–87.

    Article  Google Scholar 

  11. Kim TH, Chung KW, Lee YJ, Park CS, Lee EK, Kim TS, Kim SK, Jung YS, Ryu JS, Kim SS, Cho KH, Shin KH. The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer. Radiat Oncol. 2010;5:69.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F, Lai M, Ho R, Cheung KY, Yu BK, Chiu SK, Choi PH, Teo PM, Kwan WH, Chan AT. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol. 2007;25:4873–9.

    Article  PubMed  Google Scholar 

  13. Schwartz DL, Lobo MJ, Ang KK, Morrison WH, Rosenthal DI, Ahamad A, Evans DB, Clayman G, Sherman SI, Garden AS. Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment. Int J Radiat Oncol Biol Phys. 2009;74:1083–91.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Romesser PB, Sherman EJ, Shaha AR, Lian M, Wong RJ, Sabra M, Rao SS, Fagin JA, Tuttle RM, Lee NY. External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancer. J Surg Oncol. 2014;110:375–82.

    Article  PubMed  Google Scholar 

Suggested Readings

  • Giuliani M, Brierley J. Indications for the use of external beam radiation in thyroid cancer. Curr Opin Oncol. 2014;26:45–50.

    Article  CAS  PubMed  Google Scholar 

  • Brierley JD, Schwartz DL, Tsang RW. External beam radiotherapy for thyroid malignancy. In: Randolph GW, editor. Surgery of the thyroid and parathyroid gland. Philadelphia: Elsevier; 2013. Chapter 52.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada

    Meredith Giuliani MB & James Brierley MB

  2. Department of Radiation Oncology, Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G2M9, Canada

    Meredith Giuliani MB & James Brierley MB

Authors
  1. Meredith Giuliani MB
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James Brierley MB
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James Brierley MB .

Editor information

Editors and Affiliations

  1. Johns Hopkins University, Baltimore, Maryland, USA

    David S. Cooper

  2. Department of Internal Medicine, University of Rome, Rome, Roma, Italy

    Cosimo Durante

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Giuliani, M., Brierley, J. (2016). A Case of a Large, Invasive PTC with Gross Residual Disease (pT4) After Surgery. In: Cooper, D., Durante, C. (eds) Thyroid Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-22401-5_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-22401-5_25

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-22400-8

  • Online ISBN: 978-3-319-22401-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation